EMA draft policy on access to clinical trial data

On Monday, 24 June 2013, the European Medicines Agency (EMA) published their draft policy on publication and access to clinical trial data.  The policy is open for public consultation until 30 September 2013. EMA were recently prevented from releasing clinical … Continue reading

The value of developing a good TPP for your product in early development

There have recently been a number of articles in biopharma publications and social media suggesting that the target product profile (or TPP) is an enemy of innovation and and reduces productivity in the industry.  The authors of these articles suggest … Continue reading